682 related articles for article (PubMed ID: 31707309)
1. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
3. Evaluation of Organo [
Otaru S; Imlimthan S; Sarparanta M; Helariutta K; Wähälä K; Airaksinen AJ
Molecules; 2020 Mar; 25(5):. PubMed ID: 32156020
[TBL] [Abstract][Full Text] [Related]
4. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
[TBL] [Abstract][Full Text] [Related]
5. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
6. Pretargeted PET Imaging Using a Bioorthogonal
Billaud EMF; Belderbos S; Cleeren F; Maes W; Van de Wouwer M; Koole M; Verbruggen A; Himmelreich U; Geukens N; Bormans G
Bioconjug Chem; 2017 Dec; 28(12):2915-2920. PubMed ID: 29191024
[TBL] [Abstract][Full Text] [Related]
7. An Efficient Method for Labeling Single Domain Antibody Fragments with
Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of a Novel
Ruivo E; Elvas F; Adhikari K; Vangestel C; Van Haesendonck G; Lemière F; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
ACS Omega; 2020 Mar; 5(9):4449-4456. PubMed ID: 32175492
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brain.
Wyffels L; Thomae D; Waldron AM; Fissers J; Dedeurwaerdere S; Van der Veken P; Joossens J; Stroobants S; Augustyns K; Staelens S
Nucl Med Biol; 2014 Jul; 41(6):513-23. PubMed ID: 24768149
[TBL] [Abstract][Full Text] [Related]
11. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
[TBL] [Abstract][Full Text] [Related]
12. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
13. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation.
Selvaraj R; Giglio B; Liu S; Wang H; Wang M; Yuan H; Chintala SR; Yap LP; Conti PS; Fox JM; Li Z
Bioconjug Chem; 2015 Mar; 26(3):435-42. PubMed ID: 25679331
[TBL] [Abstract][Full Text] [Related]
14. Labeling a TCO-functionalized single domain antibody fragment with
Zhou Z; Zalutsky MR; Vaidyanathan G
Bioorg Med Chem; 2020 Sep; 28(17):115634. PubMed ID: 32773089
[TBL] [Abstract][Full Text] [Related]
15. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and ex vivo biodistribution of two
Lambidis E; Lumén D; Koskipahta E; Imlimthan S; Lopez BB; Sánchez AIF; Sarparanta M; Cheng RH; Airaksinen AJ
Nucl Med Biol; 2022; 114-115():151-161. PubMed ID: 35680503
[TBL] [Abstract][Full Text] [Related]
18. DOTA-tetrazine probes with modified linkers for tumor pretargeting.
Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS
Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502
[TBL] [Abstract][Full Text] [Related]
19. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
20. Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation.
Shah MA; Zhang X; Rossin R; Robillard MS; Fisher DR; Bueltmann T; Hoeben FJM; Quinn TP
Bioconjug Chem; 2017 Dec; 28(12):3007-3015. PubMed ID: 29129050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
